Evidence map›Paper›PMID 26031965›Full record

ArticleCurrent infectious disease reports2015

Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearance.

Stephen Y Liang, Anand Kumar

Open access · greenAbstract read
In one paragraph

Article in Current infectious disease reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 3 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 3 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Early-Onset Candidemia in Adult Intensive Care Units.Diagnostics (Basel, Switzerland) · 2025
    Review
  6. Review
  7. Article
  8. Appropriate use of colistin in neonates, infants and children: Interim guidance.Southern African journal of infectious diseases · 2023
    Article
  9. Review
  10. Review
  11. Article
  12. How to Manage Pseudomonas aeruginosa Infections.Advances in experimental medicine and biology · 2022
    Article
  13. Article
  14. Case Report: Multidrug ResistantFrontiers in veterinary science · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Antimicrobial Therapy in Septic Shock Is Conservative During Resuscitation and Maintenance Phases.The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians · 2020
    Article
  19. Article
  20. Initial clinical outcomes and prognostic variables in the implementation of a Code Sepsis in a high complexity University Hospital.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2019
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Stephen Y LiangDivision of Infectious Diseases, Division of Emergency Medicine, Washington University School of Medicine, 660 S. Euclid Avenue, Campus Box 8051, St. Louis, MO, 63110, USA, sliang@dom.wustl.edu.
Anand Kumar
Health Sciences Centre · CA

Funding

Washington University Institute of Clinical and Translational Sciences (UL1)UL1RR024992 · NCRR · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2007 to 2011
$45.4M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
WASHINGTON UNIVERSITY CER MENTORED CAREER DEVELOPMENT AWARD KM1KM1CA156708 · NCI · WASHINGTON UNIVERSITY · PI FRASER, VICTORIA J. · 2010 to 2010
$2.5M
NCATS NIH HHS UL1 TR000448NCI NIH HHS KM1 CA156708NCRR NIH HHS UL1 RR024992
6 · The paper itself

Abstract

Mortality and morbidity in severe sepsis and septic shock remain high despite significant advances in critical care. Efforts to improve outcome in septic conditions have focused on targeted, quantitative resuscitation strategies utilizing intravenous fluids, vasopressors, inotropes, and blood transfusions to correct disease-associated circulatory dysfunction driven by immune-mediated systemic inflammation. This review explores an alternate paradigm of septic shock in which microbial burden is identified as the key driver of mortality and progression to irreversible shock. We propose that clinical outcomes in severe sepsis and septic shock hinge upon the optimized selection, dosing, and delivery of highly potent antimicrobial therapy.

Identifiers

PMID26031965
PMCPMC4581522
OpenAlexW655999930

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.